Trial intelligence / Profile preview

Biomarkers for Augmentin-Induced Liver Injury in Elderly

NCT02431832Phase 1Completed

Sponsor
Seoul National University Hospital
Start
Feb 2015
Primary completion
Oct 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of amoxicillin + clavulanate in bacterial infection, sponsored by Seoul National University Hospital. Primary endpoint: Area Under Curve up to 35 days. Started Feb 2015; status: completed.

02

Drugs

amoxicillin + clavulanate
03

Conditions

bacterial infection

Beyond the preview

Go deeper on NCT02431832.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02431832.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call